12.12.2024 14:40:52
|
EQS-Adhoc: Softing AG Revises Full-Year Guidance
EQS-Ad-hoc: Softing AG / Key word(s): Change in Forecast The Executive Board of Softing AG expected to achieve for the year 2024 a sales volume of EUR 105 million and an operating EBIT of approximately EUR 4 million. As previously communicated, the achievement of these targets depended on the realization of individual large-volume and high-margin businesses. Due to a sharp decline in the business of our automotive and industrial customers, they are cancelling planned investments or postponing them into the year 2025. As a result of the weakend customer demand, the Management Board considers the previous sales and earnings expectations to be no longer achievable. The Management Board now expects revenues of between EUR 90 million and EUR 95 million, an operating EBIT of between EUR 2 million and EUR 2.5 million and a break-even EBIT. Contact: Dr. Wolfgang Trier CEO End of Inside Information
12-Dec-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Softing AG |
Richard-Reitzner-Allee 6 | |
85540 Haar | |
Germany | |
Phone: | +49 (0)89 456 56-333 |
Fax: | +49 (0)89 456 56-399 |
E-mail: | InvestorRelations@softing.com |
Internet: | www.softing.com |
ISIN: | DE0005178008 |
WKN: | 517800 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 2050219 |
End of Announcement | EQS News Service |
|
2050219 12-Dec-2024 CET/CEST
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Softing AGmehr Nachrichten
20.12.24 |
EQS-DD: Softing AG: Dr. Wolfgang Trier, Kauf (EQS Group) | |
20.12.24 |
EQS-DD: Softing AG: Dr. Wolfgang Trier, buy (EQS Group) | |
19.12.24 |
EQS-PVR: Softing AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung (EQS Group) | |
18.12.24 |
EQS-DD: Softing AG: Dr. Wolfgang Trier, Kauf (EQS Group) | |
18.12.24 |
EQS-DD: Softing AG: Dr. Wolfgang Trier, buy (EQS Group) | |
12.12.24 |
EQS-Adhoc: Softing AG korrigiert die Jahresprognose (EQS Group) | |
12.12.24 |
EQS-Adhoc: Softing AG Revises Full-Year Guidance (EQS Group) | |
21.11.24 |
EQS-PVR: Softing AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung (EQS Group) |